Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides

Inclusion Criteria(not limited to):

- General good health with no existing co-morbidities

- Body mass index (BMI) less than 35 kg/m²

- Borderline high or high fasting serum triglycerides

- Clinically normal findings for hematology, clinical chemistry, and urinalysis

- Be willing to maintain dietary habits and physical activity levels throughout the
trial period (next 4 months)

- Have a low habitual consumption of fatty fish and seafood, defined as a frequency of
twice per month or less

Exclusion Criteria (not limited to):

- Familial hypercholesterolemia or severely high total cholesterol levels

- History or presence of significant cardiovascular disease or co-morbidities

- Known allergy to crustaceans (shellfish)

- Bleeding disorders

- Disturbed absorption due to changes in the gastrointestinal tract

- Participation in a clinical trial with an investigational product within 30 days
before screening

- Present or recent use (within 3 months of screening or the first screening visit, if
applicable) of any medication which is a known lipid modifying agent or any dietary
supplements that affect the level of blood cholesterol and triglycerides

- Current or recent diet, which in the opinion of the Investigator, deviates from a
normal diet (e.g., vegetarians may be acceptable, vegans are not acceptable)

- Female patients that are pregnant or nursing or females of childbearing potential who
are not on a method of birth control acceptable to the Investigator during treatment

- Patients with known coagulopathy or receiving anticoagulant therapy or co-morbidity
that would interfere with the study results

- Frequency of fatty fish and/or seafood consumption is greater than twice per month

- Present or recent use of any long-chain omega-3 fatty acid supplement

- Peri-menopausal women or post-menopausal women taking hormone replacement therapy

- Patients who test positive for human immunodeficiency virus (HIV) or hepatitis B or C

- Systolic blood pressure greater than 159 mmHg or diastolic blood pressure greater
than 99 mmHg or use of anti-hypertensive medication

- Diabetic subjects

- Staff of Cetero Research